相关实验视频
Updated: May 13, 2026

09:49
Isolation and Cannulation of Cerebral Parenchymal Arterioles
Published on: May 23, 2016
11.6K
大脑粉样血管病变:一个单一的实体?
Emma A Koemans1, Ellis S van Etten
1Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands.
Current opinion in neurology
|January 6, 2025
概括
大脑粉样蛋白血管病变 (CAA) 涉及粉样蛋白-β的积累,导致大脑出血和痴呆. 最近的发现突出了其复杂的原因,包括清除和炎症的损害,导致疾病的进展变化.
科学领域:
- 神经学 神经学
- 神经科学是一个神经科学.
- 病理学 病理学 病理学
背景情况:
- 大脑粉样血管病变 (CAA) 是老年人群和阿尔茨海默病患者中普遍存在的大脑疾病.
- 在大脑血管中积累的胺β会导致大脑内出血和认知能力下降.
- 了解CAA的病理生理学对于管理与年龄相关的神经疾病至关重要.
研究的目的:
- 本综述综合了对CAA病理生理学理解的最新进展.
- 它探讨了CAA的各种临床表现和潜在机制.
- 其目的是为CAA研究提供最新的视角.
主要方法:
- 关于大脑粉样血管病变的最近研究的文献综述.
- 对CAA病理生理学和表型的新兴证据的分析.
- 综合与粉样β沉积,血管变化和清除机制相关的发现.
主要成果:
- CAA表现出一个漫长的临床前阶段,病理生理学进展通过粉样β沉积,血管功能障碍和出血.
- 周血管清除受损和淋巴功能障碍是导致CAA的关键因素.
- 疾病的变异性受到诸如血管重塑,免疫反应,炎症和类传播等因素的影响.
结论:
- 偶发性,遗传性,炎症性和阳性CAA形式强调了其复杂的病因.
- 大脑清除系统,炎症和血管重塑之间的相互作用驱动着不同的临床表型.
- 需要进一步的研究来阐明CAA的多面性质及其临床影响.
更多相关视频
相关概念视频
Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Cerebral Edema ll: Pathophysiology
Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...
Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...

